市場調查報告書
商品編碼
1410844
心臟瓣膜修復設備市場:市場規模(按細分市場)、份額、監管、報銷、程序、預測(~2033)Cardiac Valve Repair Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
由於退化性病因的增加,瓣膜性心臟病的盛行率隨著年齡的增長而增加。葡萄球菌性心內膜炎是瓣膜性心臟病的重要病因。主動脈瓣和二尖瓣最常受到瓣膜性心臟病的影響。二尖瓣關閉不全會導致左心房擴張、心房顫動、肺動脈壓力升高、勞力性呼吸困難。退化性二尖瓣逆流導致索狀瓣膜伸長和破裂以及瓣葉脫垂。
該報告深入探討了全球心臟瓣膜修復設備市場,包括競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響以及區域和國家趨勢。
Cardiac Valve Repair Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Cardiac Valve Repair Devices market for the year 2020 and beyond. The prevalence of valvular heart disease increases with age because of the increase in degenerative etiologies. Endocarditis which is caused by Staphylococci is an important etiology of valvular heart disease. The aortic valve and mitral valve are most commonly affected by valvular heart disease. Mitral valve regurgitation can further lead to exertional dyspnea along with left atrial dilation, atrial fibrillation, and elevated pulmonary atrial pressure. Degenerative mitral regurgitation also leads to chordal elongation or rupture and causes leaflet prolapse.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Cardiac Valve Repair Devices market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences Corp, Medtronic Plc, Abbott Laboratories, Corcym Srl, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable